|
Experience and Background
Michael L. Kichline represents clients in complex litigation, including securities fraud class actions, derivative suits, and disputes arising out of mergers and acquisitions. He is listed for securities law in The Best Lawyers in America and is also recognized as an "up and coming" securities litigation lawyer by Chambers USA, a referral guide to leading lawyers in the United States.
Bar and Court Admissions
- Member, Pennsylvania Bar
- Admitted to practice before the United States Supreme Court, the U.S. Third Circuit Court of Appeals, and the U.S. District Court for the Eastern District of Pennsylvania
Significant Representations
-- In re GlaxoSmithKline Securities Litigation
Southern District of New York
Plaintiffs' Attorneys: Stull, Stull & Brody
Defending GSK and its Chief Executive Officer in putative class actions alleging 10(b)5 claims.
-- Kassover/Brody v. OSI Pharmaceuticals
Eastern District of New York
Plaintiffs' Attorneys: Lerach, Coughlin
Defending OSI Pharmaceuticals and various officers and directors in putative class actions alleging Section 11 and 10(b)5 claims arising out of the FDA's approval of Tarceva.
-- Dura Pharmaceuticals Inc. v. Michael Broudo
United States Supreme Court
Counsel for the Respondent: Lerach, Coughlin
Preparing an amicus brief on behalf of a public interest group in support of Dura Pharmaceuticals. In this life sciences case, the Supreme Court addressed the issue of "loss causation" under the Private Securities Litigation Reform Act and, ultimately, ruled in favor of Dura.
-- In re Constar International Inc. Securities Litigation
Eastern District of Pennsylvania
Plaintiffs' Attorneys: Lerach, Coughlin
Defending Constar International and Crown Holdings in a putative securities class action related to Crown Holdings' 2002 offering, pursuant to which Constar was sold to the public. The plaintiffs allege that defendants violated Section 11 of the Securities Act of 1933 by misrepresenting various aspects of Constar's operations and accounting. The case is now in the class certification and discovery phases.
-- In re PMA Capital Corporation Securities Litigation
Eastern District of Pennsylvania
Plaintiffs' Attorneys: Milberg Weiss
Defending PMA Capital Corporation and several individuals in a putative class action alleging Section 11 and 10(b)5 claims. The claims arise out of the company's announcement that it was increasing its insurance loss reserve estimates.
-- In re Select Medical Corporation
Eastern District of Pennsylvania
Plaintiffs' Attorneys: Milberg Weiss
Defending Select Medical and several individuals in a putative class action alleging 10(b)5 claims. The claims arise out of a proposed change in Medicare regulations.
-- ABFS Litigation
Pennsylvania state court
Defending JPMorgan Chase, Morgan Stanley, and Bear Stearns in litigation arising out of the collapse of ABFS, a mortgage company
In addition, Mr. Kichline also represents clients in complex commercial matters involving contracts, business torts, consumer fraud, and civil RICO. He has tried cases in state and federal courts and has litigated numerous class actions.
Education
Mr. Kichline is a graduate of Temple University (B.A., magna cum laude, 1988) and Temple University School of Law (J.D., magna cum laude, 1991), where he was a member of the Moot Court Honor Society.
Publications and Lectures
|
